NCT00443170View on ClinicalTrials.gov

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2006

Conditions
Healthy SubjectsAnaemia
Interventions
DRUG

GSK626616, placebo, midazolam

DRUG

omeprazole, caffeine, flurbiprofen, rosiglitazone

Trial Locations (3)

2031

GSK Investigational Site, Randwick, Sydney

4006

GSK Investigational Site, Herston

5000

GSK Investigational Site, Adelaide

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY